N-(3,5-diisopropyl-4-oxocyclohexa-2,5-dien-1-ylidene)acetamide | 75531-71-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: N-(3,5-diisopropyl-4-oxocyclohexa-2,5-dien-1-ylidene)acetamide
• 英文别名: N-[4-oxo-3,5-di(propan-2-yl)cyclohexa-2,5-dien-1-ylidene]acetamide
• CAS: 75531-71-4
• 化学式: C₁₄H₁₉NO₂
• 分子量: 233.31
• InChiKey: BZVIIQNGTKNPER-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  46.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  sodium p-chlorobenzenesulphinate 、 N-(3,5-diisopropyl-4-oxocyclohexa-2,5-dien-1-ylidene)acetamide 在 溶剂黄146 作用下， 反应 6.0h， 以50%的产率得到4-hydroxy-3,5-diisopropylphenyl 4-chlorobenzenesulfonate
  参考文献：
  名称：

  N-乙酰基和N-[1-（芳基磺酰亚胺基）乙基] -1,4-苯醌亚胺与芳烃亚磺酸钠的反应

  摘要：

  根据1,4，在醌环的2-和/或6-位没有取代基的N-乙酰基和N- [1-（芳基磺酰亚胺基）乙基] -1,4-苯醌亚胺优先与芳烃亚磺酸钠反应-加法模式。ArSO 2 N基团的存在有利于自由基离子反应并形成1，6-加成产物。

  DOI：

  10.1134/s1070428014090097
• 作为产物：
  描述：

  3,5-Diisopropylparacetamol 在 4-碘化甲苯二乙酸酯 作用下， 以 二氯甲烷 为溶剂， 以53%的产率得到N-(3,5-diisopropyl-4-oxocyclohexa-2,5-dien-1-ylidene)acetamide
  参考文献：
  名称：

  N-乙酰基和N-[1-（芳基磺酰亚胺基）乙基] -1,4-苯醌亚胺与芳烃亚磺酸钠的反应

  摘要：

  根据1,4，在醌环的2-和/或6-位没有取代基的N-乙酰基和N- [1-（芳基磺酰亚胺基）乙基] -1,4-苯醌亚胺优先与芳烃亚磺酸钠反应-加法模式。ArSO 2 N基团的存在有利于自由基离子反应并形成1，6-加成产物。

  DOI：

  10.1134/s1070428014090097

文献信息

• Burmistrov, K. S.; Burmistrov, S. I., Journal of Organic Chemistry USSR (English Translation), 1980, vol. 16, # 7, p. 1279 - 1284
  作者：Burmistrov, K. S.、Burmistrov, S. I.

  DOI：——

  日期：——
• Rat liver microsomal cytochrome P450-dependent oxidation of 3,5-disubstituted analogues of paracetamol
  作者：J. G. M. Bessems、J. M. Te Koppele、P. A. Van Dijk、L. L. P. Van Stee、J. N. M. Commandeur、N. P. E. Vermeulen

  DOI：10.3109/00498259609046740

  日期：1996.1

  1. The cytochrome P450-dependent binding of paracetamol and a series of 3,5-disubstituted paracetamol analogues (R = -F, -Cl, -Br, -I, -CH3, -C2H5, -iC(3)H(7)) have been determined with beta-naphthoflavone (beta NF)-induced rat liver microsomes and produced reverse type I spectral changes. K-s,K-app varied from 0.14 mM for 3,5-diiC(3)H(7)-paracetamol to 2.8 mM for paracetamol.2. All seven analogues underwent rat liver microsomal cytochrome P450-dependent oxidation, as reflected by the formation of GSSG in the presence of GSH. The GSSG-formation was increased in all cases upon pretreatment of rats by beta-naphthoflavone (beta NF) and was generally decreased upon pretreatment by phenobarbital (PB).3. Rat liver microsomal cytochrome P450 as well as horseradish peroxidase catalysed the formation of 3,5-disubstituted NAPQI analogues from the corresponding parent compounds, as identified by UV-spectrophotometry of the NAPQI analogues and by GC/MS detection of the following GSH-conjugates: 2-glutathione-S-yl-3,5-dimethyl-1,4-dihydroxybenzene, 2-glutathione-S-yl-3,5-dichloro-paracetamol, and 2-glutathione-S-yl-3,5-dibromo-paracetamol.4. In liver microsomal (beta NF-induced) incubations, apparent K,values, as determined for the cytochrome P450 catalysis-dependent oxidation of GSH, for seven 3,5-disubstituted paracetamol analogues (R = -F, -Cl, -Br, -I, -CH3, -C2H5, iC(3)H(7)) varied from 0.07 to 0.64 mM. Paracetamol exhibited an apparent K-m of 0.73 mM. Apparent V-max values for the cytochrome P450 catalysis dependent oxidation of GSH varied from 0.66 nmol min(-1) mg(-1)protein for paracetamol to 3.0 nmol min(-1) mg(-1) protein for 3,5-dimethyl-paracetamol.